ARIA CV
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart.
ARIA CV
Social Links:
Industry:
Health Care Medical Device Wellness
Founded:
2010-04-15
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.ariacv.com
Total Employee:
11+
Status:
Active
Total Funding:
53.72 M USD
Technology used in webpage:
Euro U.S. Server Location Comcast
Similar Organizations
Companion Medical
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
LivWell
LivWell is dispensary company that provides exceptional cannabis products.
Magnamosis
Magnamosis develops a medical device designed to create a magnetic compression anastomosis with improved outcomes.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Investors List
Portfolia
Portfolia investment in Series B - Aria CV
BioStar Capital
BioStar Capital investment in Series B - Aria CV
Cedar Point Capital
Cedar Point Capital investment in Series B - Aria CV
Frontcourt Ventures
Frontcourt Ventures investment in Series B - Aria CV
Longview Ventures
Longview Ventures investment in Series B - Aria CV
Catalyst Health Ventures
Catalyst Health Ventures investment in Series B - Aria CV
Xeraya Capital
Xeraya Capital investment in Series B - Aria CV
Synergy Partners International
Synergy Partners International investment in Series B - Aria CV
Brightstone Venture Capital
Brightstone Venture Capital investment in Series B - Aria CV
Christina Jenkins
Christina Jenkins investment in Series B - Aria CV
Official Site Inspections
http://www.ariacv.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aria CV"
Story Behind Our Device To Treat Pulmonary …
John Scandurra, DVM, MS Dr. Scandurra is a co-founder and Chief Scientific Officer at Aria. He is responsible for managing Aria’s Scientific Advisory Board, promoting Aria’s novel therapy within the pulmonary hypertension physician …See details»
Aria CV - Crunchbase Company Profile & Funding
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center.See details»
Aria CV, Inc. | LinkedIn
Aria CV, Inc. | 837 followers on LinkedIn. Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.See details»
Aria CV Company Profile 2024: Valuation, Funding
Aria CV General Information Description. Developer of an implantable cardiovascular device designed to treat pulmonary hypertension. The company's devices reduce the workload on the heart and have the potential to enhance …See details»
Contact Us | Aria CV | Device To Treat Pulmonary Hypertension
Contact the Aria CV team about the novel implantation device designed to treat pulmonary hypertension (PH).See details»
ARIA CV - Overview, News & Similar companies | ZoomInfo.com
ARIA CV contact info: Phone number: (651) 200-4892 Website: www.ariacv.com What does ARIA CV do? Based in St. Paul, Minnesota, Aria CV was founded in 2010 by Drs. John Scandurra …See details»
Aria CV - VentureRadar
"Aria CV is developing a medical device designed to improve the lives of patients living with the disease of pulmonary hypertension. Aria CV was founded in 2010 by Drs. John Scandurra and …See details»
Aria CV Announces First Patient Successfully Implanted …
Feb 29, 2024 Ascension is a faith-based healthcare organization committed to delivering compassionate, personalized care to all, with special attention to persons living in poverty and those most vulnerable. Ascension includes …See details»
Aria CV, Inc. Closes on $7.8 million Series A Financing
SAINT PAUL, MN — Aria CV, Inc., a developer of medical devices treating pulmonary hypertension, a serious condition that may lead to heart failure, today announced the closing …See details»
Aria CV Announces First Patient Successfully Implanted with …
SAINT PAUL, Minn., February 27, 2024--Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria …See details»
Aria CV - Craft
Aria CV is a company that develops implantable cardiovascular devices designed to treat pulmonary hypertension. Its devices reduce the workload on the heart and have the potential …See details»
Device for Treating Pulmonary Arterial Hypertension Aria CV …
F e b r u a r y 0 6 , 2 0 2 0 0 7 : 0 0 A M E a st e r n S t a n d a r d Ti m e SAINT PAUL, Minn.--( BUSINESS WIRE )--Aria CV, Inc., a developer of medical devices treating Pulmonary ArterialSee details»
Pulmonary Hypertension Device by Aria CV Gets FDA …
Feb 12, 2020 The Aria CV PH System is designed to reduce the symptoms associated with PH — a condition that develops due to high blood pressure in the pulmonary arteries (blood …See details»
Aria Raises $31M for Planned Study of Balloon Implant to Treat PAH
Mar 2, 2020 The series B round, which raised $31 million, was led by Xeraya Capital. “Aria CV is now well positioned to drive our clinical research forward,” Dan Gladney, the company’s chief …See details»
Aria CV Announces First Patient Successfully Implanted with …
Ascension is a faith-based healthcare organization committed to delivering compassionate, personalized care to all, with special attention to persons living in poverty and those most …See details»
Aria CV | Catalyst Health Ventures
Jul 24, 2015 Aria CV is developing a novel, implantable medical device for the treatment of pulmonary hypertension. Aria’s device is designed to mimic the function of the healthy …See details»
Science Behind Our Device For Pulmonary Hypertension - Aria CV
Aria’s device is designed to treat a form of PH called World Health Organization (WHO) Group 1 PH, also known as Pulmonary Arterial Hypertension (PAH). The walls of a healthy pulmonary …See details»
1st patient implanted with Aria CV balloon system as PAH treatment
Feb 28, 2024 The Gen 2 system was designed to restore the normal function of the pulmonary artery, with an aim of reducing the workload on heart muscles and increasing blood flow in …See details»
Top 10 Emerging Cardio Vascular Devices Companies - Medical …
ARIA CV offers a novel implantable medical device designed to treat pulmonary hypertension, a progressive and deadly disease that impacts over 70 million people worldwide. Aria’s device is …See details»